相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
John Q. Trojanowski et al.
ALZHEIMERS & DEMENTIA (2010)
Use of Cerebrospinal Fluid Biomarkers for Diagnosis of Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
Robert A. Dean et al.
CLINICAL CHEMISTRY (2010)
Total and phosphorylated tau protein as biological markers of Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL GERONTOLOGY (2010)
Biological markers of amyloid β-related mechanisms in Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Decreased Cerebrospinal Fluid Aβ42 Correlates with Brain Atrophy in Cognitively Normal Elderly
Anne M. Fagan et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
Barbara J. Snider et al.
ARCHIVES OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
Timo Grimmer et al.
BIOLOGICAL PSYCHIATRY (2009)
Validation of Alzheimer's disease CSF and plasma biological markers: The multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)
Katharina Buerger et al.
EXPERIMENTAL GERONTOLOGY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Biomarkers of Alzheimer's disease
Rebecca Craig-Schapiro et al.
NEUROBIOLOGY OF DISEASE (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
N. A. Verwey et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
G. Li et al.
NEUROLOGY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
CSF A beta 42, Tau and phosphorylated Tau, APOE epsilon 4 allele and MCI type in progressive MCI
Sanna-Kaisa Herukka et al.
NEUROBIOLOGY OF AGING (2007)
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Leslie M. Shaw et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
International quality control survey of neurochemical dementia diagnostics
Piotr Lewczuk et al.
NEUROSCIENCE LETTERS (2006)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Diagnosing prodromal Alzheimer's disease: Role of CSF biochemical markers
L Parnetti et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides
P Lewczuk et al.
CLINICAL CHEMISTRY (2006)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: Implications for use in clinical practice
NSM Schoonenboom et al.
CLINICAL CHEMISTRY (2005)
Amyloid β(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease
NSM Schoonenboom et al.
NEUROLOGY (2004)
Cerebrospinal fluid tau and β-amyloid -: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
CM Clark et al.
ARCHIVES OF NEUROLOGY (2003)
Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease
RA Frank et al.
NEUROBIOLOGY OF AGING (2003)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
分享论文
